ANTERIS TECHNOLOGIES GLOBAL CORP.ANTERIS TECHNOLOGIES GLOBAL CORP.ANTERIS TECHNOLOGIES GLOBAL CORP.

ANTERIS TECHNOLOGIES GLOBAL CORP.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪321.66 M‬AUD
−5.05AUD
‪−67.33 M‬AUD
‪4.11 M‬AUD
‪32.29 M‬
Beta (1Y)
2.21

About ANTERIS TECHNOLOGIES GLOBAL CORP.


CEO
Wayne Geoffrey Paterson
Headquarters
Toowong
Founded
1999
ISIN
AU0000088841
FIGI
BBG000BS9158
Anteris Technologies Ltd. is a structural heart company, which engages in research, develops, commercializes, and distributes medical technologies and devices. It operates through the following geographical segments: Australia, United States, and Switzerland. It manufactures, distributes, and sells ADAPT and DurAVR regenerative tissue products, and researches and develops regenerative medicine and immunotherapies. The company was founded on June 23, 1999 and is headquartered in Toowong, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.